Pages

Search This Blog

Sunday, October 30, 2022

Analysis of Thromboembolic and Thrombocytopenic Events After the AZD1222, BNT162b2, and MRNA-1273 COVID-19 Vaccines in 3 Nordic Countries | Clinical Pharmacy and Pharmacology | JAMA Network Open | JAMA Network

Analysis of Thromboembolic and Thrombocytopenic Events After the AZD1222, BNT162b2, and MRNA-1273 COVID-19 Vaccines in 3 Nordic Countries | Clinical Pharmacy and Pharmacology | JAMA Network Open | JAMA Network

No comments: